Welcome

U.S. to Supply Covid Drugs Based on Cases Amid Delta Surge (2)

Sept. 15, 2021, 12:00 AM

The U.S. government plans to more directly control where Covid-19 antibody treatments are sent amid a surge in infections and hospitalizations in states with large pockets of unvaccinated people.

Hospitals and other care providers will no longer be able to directly order monoclonal antibody therapies from distributors, according to a Sept. 13 update posted on the Department of Health and Human Services website.

Instead, the U.S. government will determine what quantity of the drugs to ship to each state and territory based on Covid-19 case numbers and use of the treatments locally. State health departments will then determine how to ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.